Erectile dysfunction (ED), also known as impotence, is a type of sexual dysfunction characterized by the inability to develop or maintain an erection of the penis during sexual activity. Erectile dysfunction can have psychological consequences as it can be tied to relationship difficulties and self-image.
This report contains market size and forecasts of Erectile Dysfunction in global, including the following market information:
Global Erectile Dysfunction Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Erectile Dysfunction Market Sales, 2017-2022, 2023-2028, (Million Pill)
Global top five Erectile Dysfunction companies in 2021 (%)
The global Erectile Dysfunction market was valued at 5004.7 million in 2021 and is projected to reach US$ 7899.3 million by 2028, at a CAGR of 6.7% during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Sildenafil Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Erectile Dysfunction include Eli Lilly, Pfizer, Bayer, BaiYunShan General Factory, S.K. Chemicals, Teva Pharma, Dong-A ST, Petros Pharmaceuticals and Seoul Pharma and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Erectile Dysfunction manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Erectile Dysfunction Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Million Pill)
Global Erectile Dysfunction Market Segment Percentages, by Type, 2021 (%)
Sildenafil
Tadalafil
Others
Global Erectile Dysfunction Market, by Sales Channels, 2017-2022, 2023-2028 ($ Millions) & (Million Pill)
Global Erectile Dysfunction Market Segment Percentages, by Sales Channels, 2021 (%)
Hospital Pharmacies
Private Clinics
Retail Pharmacies
E-Commerce (B2B)
E-Commerce (B2C)
Global Erectile Dysfunction Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (Million Pill)
Global Erectile Dysfunction Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Erectile Dysfunction revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Erectile Dysfunction revenues share in global market, 2021 (%)
Key companies Erectile Dysfunction sales in global market, 2017-2022 (Estimated), (Million Pill)
Key companies Erectile Dysfunction sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Eli Lilly
Pfizer
Bayer
BaiYunShan General Factory
S.K. Chemicals
Teva Pharma
Dong-A ST
Petros Pharmaceuticals
Seoul Pharma
Yabang Pharmacy